Literature DB >> 25661450

Endovascular aneurysm repair of aortoiliac aneurysms with an iliac side-branched stent graft: studying the morphological applicability of the Cook device.

D Gray1, R Shahverdyan1, C Jakobs1, J Brunkwall2, M Gawenda1.   

Abstract

OBJECTIVE/
BACKGROUND: Endovascular aneurysm (EVAR) repair of an aortic aneurysm extending to the iliac artery remains a challenge. Interventional occlusion of the internal iliac artery (IIA) intending to create a distal landing zone in the external iliac artery is a common approach with inherent morbidity (e.g., buttock claudication, impotence). Alternatively, iliac side-branched stent grafts can maintain pelvic blood supply, but the applicability is limited. The objective was to investigate the morphological applicability of the Cook Zenith branched graft (ZBIS) among patients with aorto-iliac or isolated iliac aneurysms.
METHODS: This was a retrospective single centre analysis of 66 patients (60 men; median age 74 years, range 53-90 years) undergoing repair of aorto-iliac aneurysms (open repair, IIA occlusion prior to EVAR and ZBIS) between January 2008 and December 2012. All available computed tomography angiograms with post-processing imaging were compared with the criteria for morphological applicability to (i) the manufacturer's instruction for use (IFU), and (ii) to criteria published in the literature, as well as (iii) to the institutional protocol.
RESULTS: In 66 patients, 88 targeted iliac aneurysms were studied. Of these, 36/88 (40.9%) were compliant with the manufacturer's IFU, 35/88 (39.8%) were compliant with the published criteria, and 51/88 (58.0%) were compliant with the in house protocol. The most common morphological exclusion criterion was an aneurysmal IIA.
CONCLUSION: In the present cohort with aorto-iliac aneurysm, a maximum of 58% could have been treated with an iliac side branch based on the current experience. In particular, an aneurysmal IIA seems to be a limiting factor for the use of the iliac side-branched stent graft.
Copyright © 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25661450     DOI: 10.1016/j.ejvs.2014.12.021

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  5 in total

1.  Outcomes of Endovascular Repair of Aortoiliac Aneurysms and Analyses of Anatomic Suitability for Internal Iliac Artery Preserving Devices in Japanese Patients.

Authors:  Nathan K Itoga; Naoki Fujimura; Keita Hayashi; Hideaki Obara; Hideyuki Shimizu; Jason T Lee
Journal:  Circ J       Date:  2017-02-02       Impact factor: 2.993

2.  Successful endovascular repair of iliac artery aneurysms with unsuitable anatomy by combining unibody bifurcated endograft and iliac branch systems to preserve hypogastric artery blood flow: a report of two cases.

Authors:  Daisuke Akagi; Kai Murase
Journal:  J Cardiothorac Surg       Date:  2022-05-03       Impact factor: 1.637

3.  Endovascular repair of bilateral common iliac artery aneurysms using GORE Excluder iliac branch endoprosthesis without aortobi-iliac stent graft conjunction: A case report.

Authors:  Vincenzo Ardita; Alessia Giaquinta; Massimiliano Veroux; Angelo Sanfiorenzo; Carla Virgilio; Giuseppe D'Arrigo; Pierfrancesco Veroux
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

4.  Bifurcated unibody aortic endografts can overcome unfavorable aortoiliac anatomy for deployment of bilateral iliac branch endoprostheses.

Authors:  Arash Fereydooni; Christine Deyholos; Robert Botta; Nariman Nezami; Alan Dardik; Naiem Nassiri
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-05-25

5.  A Multicenter Assessment of Anatomic Suitability for Iliac Branched Devices in Eastern Asian Patients With Unilateral and Bilateral Aortoiliac Aneurysms.

Authors:  Zheyun Li; Min Zhou; Guili Wang; Tong Yuan; Enci Wang; Yufei Zhao; Xiaolong Shu; Yuchong Zhang; Peng Lin; Weiguo Fu; Lixin Wang
Journal:  Front Cardiovasc Med       Date:  2022-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.